trastuzumab,tucatinib,trastuzumab deruxtecan,zanidatamab,pembrolizumab,zanidatamab
daiichi sankyo,seagen,merck,astrazeneca,jazz
['destiny,gastric 02', '#gi', 'zanidatamab', 'tucatinib', 'gastric', 'mountaineer', 'gi ', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'herizonbtc01', 'zanida', 'destiny,gastric02', 'key,note,811']
#wcgic2023 emerging in #gi cancer dr. van cutsem + dr. carnero her2 t-dxt for #gastriccancer #destinygastric01 2nd line #fda --&gt; #destinygastric02 trastuzumab + tucatinib for #ccr #mountaineer zanidatamab #biliarytract #herizonbtc01 
Medical Oncologist MD, Vall d'Hebron @vallhebron @VHIO
Drug Development

Vocal Junta Govern @COMBarcelona

Asesor @SalutUIC
#GBM #PhaseI #oncology